Why CRISPR-Edited Food May Be in Supermarkets Sooner Than You Think
By Kristen V. Brown,
Gizmodo
| 01. 16. 2018
In September, the U.S. Department of Agriculture gave the green light to a version of the plant Camelina sativa, an important oilseed crop that had been genetically engineered using CRISPR to produce enhanced omega-3 oil. What was interesting about this approval was that the USDA did not ask that the inventors of the plant endure the usual regulatory hoops required to sell biotech crops. The next month, a drought-tolerant soybean variety developed with CRISPR also got a quick pass from the USDA.
That’s because while those crops were certainly gene-edited, they were not genetically “modified,” according to USDA regulations. While scientists used CRISPR to snip and tweak the plant’s DNA, they did not add any foreign DNA to it. This, the USDA has now repeatedly found, means those CRISPR-edited plants fall outside of regulatory purview.
An interview in Nature with the CEO of Yield10 Bioscience, which developed the camelina, gives new insight into how that regulatory technicality is already making it significantly faster and cheaper to bring new biotech plants to market—shaving years and tens of millions of dollars...
Related Articles
GeneWatch UK has prepared a briefing on the genetic modification of nature for the International Union for Conservation of Nature (IUCN) Congress in October 2025
The upcoming Congress claims to be “where the world comes together to set priorities and drive conservation and sustainable development action.” A major concern for those on the outside is that the Congress may advance plans to develop and encourage the use of synthetic biology in nature conservation. This could at first glance sound like...
By Peter de Kruijff, ABC News | 09.16.2025
Do you wonder where your meat comes from? Maybe it is organic, wild harvested, or farmed.
Or perhaps it was designed in a lab.
Faster-growing fish, heat-tolerant cows and disease-resistant pigs are among a new class of animals that are...
By Roni Caryn Rabin, The New York Times | 08.25.2025
Scientists have dreamed for centuries about using animal organs to treat ailing humans. In recent years, those efforts have begun to bear fruit: Researchers have begun transplanting the hearts and kidneys of genetically modified pigs into patients, with varying degrees...
By Staff, GMWatch | 08.10.2025
Protesting Against Monsanto and GMOs
by William Murphy, CC2.0
GMWatch has published a series of interviews with the late scientist Dr Arpad Pusztai, conducted in March 2002 by the journalist Andy Rowell, as part of his research for his book, Don't...
